Oligomerix Obtains $400,000 New Funding Round

  • Feed Type
  • Date
    4/15/2015
  • Company Name
    Oligomerix
  • Mailing Address
    3960 Broadway New York, NY 10032 USA
  • Company Description
    OLIGOMERIX Inc., is a biopharmaceutical company focused on developing novel drug discovery targets and therapeutics for Alzheimer’s disease and other neurodegenerative disorders. Founded in 2006, OLIGOMERIX has filed patents on tau protein oligomers (soluble aggregates) for drug and biomarker discovery.
  • Website
    http://www.oligomerix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $400,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor